UBS Group’s Theravance Biopharma TBPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.4M | Buy |
764,105
+193,680
| +34% | +$3.43M | ﹤0.01% | 3117 |
|
|
2025
Q4 | $10.7M | Buy |
570,425
+56,255
| +11% | +$933K | ﹤0.01% | 3222 |
|
|
2025
Q3 | $7.51M | Buy |
514,170
+117,037
| +29% | +$1.48M | ﹤0.01% | 3606 |
|
|
2025
Q2 | $4.38M | Sell |
397,133
-20,488
| -5% | -$199K | ﹤0.01% | 4019 |
|
|
2025
Q1 | $3.73M | Buy |
417,621
+243,376
| +140% | +$2.26M | ﹤0.01% | 4081 |
|
|
2024
Q4 | $1.64M | Buy |
174,245
+143,488
| +467% | +$1.31M | ﹤0.01% | 4918 |
|
|
2024
Q3 | $248K | Sell |
30,757
-3,015
| -9% | -$26.1K | ﹤0.01% | 5710 |
|
|
2024
Q2 | $286K | Sell |
33,772
-25,317
| -43% | -$228K | ﹤0.01% | 5413 |
|
|
2024
Q1 | $530K | Sell |
59,089
-11,917
| -17% | -$110K | ﹤0.01% | 5164 |
|
|
2023
Q4 | $798K | Buy |
71,006
+17,288
| +32% | +$174K | ﹤0.01% | 4687 |
|
|
2023
Q3 | $464K | Buy |
53,718
+11,007
| +26% | +$106K | ﹤0.01% | 4716 |
|
|
2023
Q2 | $442K | Buy |
42,711
+15,987
| +60% | +$177K | ﹤0.01% | 4924 |
|
|
2023
Q1 | $290K | Buy |
26,724
+18,068
| +209% | +$191K | ﹤0.01% | 5112 |
|
|
2022
Q4 | $97.1K | Buy |
8,656
+8,556
| +8,556% | +$89.9K | ﹤0.01% | 6131 |
|
|
2022
Q3 | $1K | Sell |
100
-193
| -66% | -$1.81K | ﹤0.01% | 10039 |
|
|
2022
Q2 | $2K | Sell |
293
-3,256
| -92% | -$30K | ﹤0.01% | 9616 |
|
|
2022
Q1 | $34K | Buy |
3,549
+1,101
| +45% | +$10.8K | ﹤0.01% | 6881 |
|
|
2021
Q4 | $27K | Buy |
2,448
+1,683
| +220% | +$14.7K | ﹤0.01% | 7505 |
|
|
2021
Q3 | $6K | Buy |
765
+665
| +665% | +$7.44K | ﹤0.01% | 8447 |
|
|
2021
Q2 | $1K | Sell |
100
-218,938
| -100% | -$4.11M | ﹤0.01% | 9192 |
|
|
2021
Q1 | $4.47M | Buy |
219,038
+50,839
| +30% | +$966K | ﹤0.01% | 2733 |
|
|
2020
Q4 | $2.99M | Buy |
168,199
+85,425
| +103% | +$1.53M | ﹤0.01% | 2986 |
|
|
2020
Q3 | $1.22M | Buy |
82,774
+80,249
| +3,178% | +$1.5M | ﹤0.01% | 3497 |
|
|
2020
Q2 | $53K | Sell |
2,525
-1,953
| -44% | -$50.2K | ﹤0.01% | 5807 |
|
|
2020
Q1 | $104K | Buy |
4,478
+1,953
| +77% | +$48.9K | ﹤0.01% | 5261 |
|
|
2019
Q4 | $65K | Sell |
2,525
-197,577
| -99% | -$3.84M | ﹤0.01% | 6216 |
|
|
2019
Q3 | $3.9M | Buy |
200,102
+192,545
| +2,548% | +$3.89M | ﹤0.01% | 2614 |
|
|
2019
Q2 | $123K | Buy |
7,557
+2,611
| +53% | +$52.9K | ﹤0.01% | 5246 |
|
|
2019
Q1 | $112K | Sell |
4,946
-24,546
| -83% | -$622K | ﹤0.01% | 4989 |
|
|
2018
Q4 | $754K | Buy |
29,492
+23,324
| +378% | +$630K | ﹤0.01% | 3926 |
|
|
2018
Q3 | $201K | Buy |
6,168
+3,083
| +100% | +$84K | ﹤0.01% | 5060 |
|
|
2018
Q2 | $70K | Sell |
3,085
-1,426
| -32% | -$33.9K | ﹤0.01% | 5727 |
|
|
2018
Q1 | $109K | Buy |
4,511
+2,117
| +88% | +$58.1K | ﹤0.01% | 5168 |
|
|
2017
Q4 | $67K | Sell |
2,394
-4,825
| -67% | -$143K | ﹤0.01% | 5622 |
|
|
2017
Q3 | $247K | Buy |
7,219
+4,794
| +198% | +$157K | ﹤0.01% | 4708 |
|
|
2017
Q2 | $96K | Buy |
2,425
+2,225
| +1,113% | +$85.5K | ﹤0.01% | 5197 |
|
|
2017
Q1 | $7K | Hold |
200
| – | – | ﹤0.01% | 6830 |
|
|
2016
Q4 | $6K | Sell |
200
-3,083
| -94% | -$95.6K | ﹤0.01% | 7167 |
|
|
2016
Q3 | $119K | Buy |
3,283
+2,319
| +241% | +$64.6K | ﹤0.01% | 4901 |
|
|
2016
Q2 | $21K | Sell |
964
-451
| -32% | -$9.74K | ﹤0.01% | 6271 |
|
|
2016
Q1 | $26K | Sell |
1,415
-4,146
| -75% | -$67.8K | ﹤0.01% | 6012 |
|
|
2015
Q4 | $91K | Buy |
5,561
+5,061
| +1,012% | +$80.3K | ﹤0.01% | 5293 |
|
|
2015
Q3 | $6K | Sell |
500
-374
| -43% | -$4.76K | ﹤0.01% | 7618 |
|
|
2015
Q2 | $12K | Hold |
874
| – | – | ﹤0.01% | 7319 |
|
|
2015
Q1 | $15K | Sell |
874
-1,931
| -69% | -$35.4K | ﹤0.01% | 7292 |
|
|
2014
Q4 | $42K | Buy |
+2,805
| New | +$48.9K | ﹤0.01% | 6704 |
|
Other funds holding TBPH
MAP
WAM
NM
ICM
VCM
